COCP Cocrystal Pharma, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 13, 2026
$1,15
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,7652 haftanın en düşüğü
$2,0352 haftanın en yükseği
Piyasa Değeri (MRQ)
$16M
P/E
-1.5
Hisse Başına Kâr
$-0.78
rozetleriniz
52 Haftlık Aralık
$1–$2
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$9
P/E
-1.5
ROE
-151.4%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
COCP Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.15
Piyasa Değeri (MRQ)
$16M
P/E
-1.5
Hisse Başına Kâr
$-0.78
ROE
-151.4%
52 Haftlık Aralık
$1–$2
COCP Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 11 Ekim 2022 | 1-for-12 | Ters |
| 24 Ocak 2018 | 1-for-30 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir·2019-12-31 → 2020-12-31
Hisse Başına Kâr$-0.782016-12-31 → 2025-12-31
Serbest Nakit Akışı$-8M2018-12-31 → 2025-12-31
Net kar marjı·2018-12-31 → 2020-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | COCP | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -1.55Y ort. ≈-0.9 | ≈-0.9 | · | · | |
| P/S (F/S) | 7.95Y ort. ≈101.5 | ≈101.5 | · | · | |
| F/D (MRQ) | 15.15Y ort. ≈3.6 | ≈3.6 | 2.6 | Aşırı değerli | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | -1.95Y ort. ≈-15.8 | ≈-15.8 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -1.95Y ort. ≈-15.9 | ≈-15.9 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 2.55Y ort. ≈3.7 | ≈3.7 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | COCP | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -76.2%5Y ort. ≈-60.1% | ≈-60.1% | -12.4% | Zayıf | |
| ROE | -151.4%5Y ort. ≈-103.4% | ≈-103.4% | -57.6% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | COCP | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 1.25Y ort. ≈20.0 | ≈20.0 | 2.3 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 3.25Y ort. ≈19.0 | ≈19.0 | 1.1 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
14.2%
Sonraki Rapor
Kas 12, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 13, 2026 | $-0.23 | $-0.17 | -36.7% |
| 31 Mart 2026 | May 15, 2026 | $-0.17 | $-0.15 | -11.1% |
| 31 Aralık 2025 | $-0.17 | $-0.18 | 4.8% | |
| 30 Eylül 2025 | $-0.19 | $-0.21 | 11.3% | |
| 30 Haziran 2025 | $-0.20 | $-0.31 | 34.6% | |
| 31 Mart 2025 | $-0.23 | $-0.52 | 55.3% | |
| 31 Aralık 2024 | $-0.32 | $-0.54 | 40.8% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $2M | $7M | · | · | · | · | · | |
| R&D Expense | $5M | $13M | $15M | $12M | $9M | $6M | $4M | $5M | $6M | $102M | $47M | $4M | |
| SG&A Expense | $4M | $5M | $6M | $6M | $5M | $6M | $5M | $4M | $2M | $4M | $7M | $2M | |
| Operating Expenses | $9M | $18M | $19M | $39M | $14M | $12M | $55M | $63M | $8M | $106M | $54M | $6M | |
| Operating Income | $-9M | $-18M | $-19M | $-39M | $-14M | $-10M | $-48M | $-63M | $-8M | $-106M | $-54M | $-6M | |
| Interest Expense | · | · | $-640.0K | $2.0K | $4.0K | $8.0K | $19.0K | $58.0K | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | $-7.0K | $126.0K | $180.0K | $96.0K | |
| Other Non-op | $188.0K | $374.0K | $575.0K | $-8.0K | $36.0K | $-62.0K | $237.0K | $294.0K | $769.0K | $2M | $-11M | $6M | |
| Pretax Income | $-9M | $-19M | · | · | · | $-10M | $-48M | $-63M | $-7M | $-104M | $-65M | $-151.0K | |
| Income Tax | · | · | · | · | · | · | · | $-14M | $-7M | $-29M | $-15M | $-52.0K | |
| Net Income | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| EPS (Basic) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | $-0.16 | · | · | · | $-0.03 | $-3.18 | $-2.40 | $0.00 | |
| EPS (Diluted) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · | · | · | · | $-0.03 | $-3.30 | $-2.40 | $-0.01 | |
| Shares (Basic) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | 7,364,000 | · | 31,859 | 28,009 | 24,126,000 | 23,518,000 | 21,011,000 | 326,779,000 | |
| Shares (Diluted) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | · | · | · | · | 24,126,000 | 23,533,000 | 21,011,000 | 327,753,000 | |
| EBITDA | $-9M | $-18M | · | $-39M | $-14M | $-10M | $-48M | $-63M | · | · | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $26M | $37M | $59M | $33M | $7M | $3M | $748.0K | $4M | $9M | $4M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Receivables | · | · | · | · | · | $556.0K | $644.0K | · | $1.0K | $21.0K | $32.0K | $122.0K | |
| Prepaid Expense | $328.0K | $430.0K | $2M | $2M | $568.0K | $399.0K | $169.0K | $191.0K | $105.0K | $517.0K | $441.0K | $144.0K | |
| Current Assets | $8M | $12M | $29M | $40M | $59M | $34M | $8M | $3M | $2M | $5M | $10M | $6M | |
| PP&E (Net) | $93.0K | $153.0K | $271.0K | $342.0K | $453.0K | $591.0K | $431.0K | $384.0K | $119.0K | $280.0K | $430.0K | $284.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $983.0K | $1M | $1M | $1M | $949.0K | |
| Goodwill | · | · | · | · | $19M | $19M | $19M | $65M | $65M | $65M | $65M | $65M | |
| Total Assets | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Accounts Payable | $890.0K | $2M | $1M | $614.0K | $578.0K | $657.0K | $2M | $616.0K | $494.0K | $563.0K | · | $299.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $563.0K | $3M | $693.0K | |
| Current Liabilities | $2M | $2M | $3M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $7M | $9M | |
| Capital Leases | $1M | $2M | $2M | $57.0K | $291.0K | $345.0K | $523.0K | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $14M | $20M | $50M | $65M | |
| Total Liabilities | $3M | $4M | $5M | $1M | $2M | $2M | $3M | $2M | $16M | $23M | $57M | $74M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $50M | $65M | |
| Common Stock | $13.0K | $10.0K | $10.0K | $8.0K | $8.0K | $71.0K | $36.0K | $30.0K | $24.0K | $24.0K | $694.0K | $123.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $243M | $240M | $229M | $19M | |
| Retained Earnings | $-342M | $-333M | $-316M | $-298M | $-259M | $-245M | $-235M | $-187M | $-138M | $-137M | $-63M | $-12M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $0 | $236.0K | |
| Stockholders' Equity | $6M | $10M | $26M | $40M | $78M | $53M | $26M | $67M | $105M | $102M | $168M | $7M | |
| Liabilities + Equity | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Shares Outstanding | 13,784,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 70,439,000 | 35,150,000 | 29,938,000 | 24,275,000 | 23,801,000 | 694,396,000 | 122,494 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $72.0K | $126.0K | $189.0K | $185.0K | $190.0K | $157.0K | $98.0K | $6.0K | $101.0K | $201.0K | $192.0K | $199.0K | |
| Stock-based Comp | $270.0K | $643.0K | $801.0K | $855.0K | $724.0K | $662.0K | $351.0K | $562.0K | $614.0K | $548.0K | $3M | $38.0K | |
| Deferred Tax | · | · | · | · | · | · | $-14M | $-14M | $-7M | $-29M | $-15M | $-54.0K | |
| Operating Cash Flow | $-8M | $-16M | $-15M | $-21M | $-13M | $-10M | $-2M | $-8M | $-7M | $-15M | $-10M | $-6M | |
| CapEx | $12.0K | $8.0K | $118.0K | $74.0K | $52.0K | $240.0K | $145.0K | $28.0K | $40.0K | $51.0K | $339.0K | $5.0K | |
| Investing Cash Flow | $-12.0K | $-8.0K | $-118.0K | $-74.0K | $-52.0K | $-240.0K | $-145.0K | $1M | $-40.0K | $3.0K | $-262.0K | $6M | |
| Stock Issued | $154.0K | · | $4M | · | $39M | $36M | $7M | $8M | $3M | $9M | $16M | · | |
| Net Stock Activity | $154.0K | · | · | · | $39M | $36M | $7M | $8M | · | · | · | · | |
| Financing Cash Flow | $5M | · | $4M | $-27.0K | $38M | $36M | $6M | $9M | $4M | $9M | $16M | $3M | |
| Net Change in Cash | $-3M | $-16M | $-11M | $-22M | $26M | $26M | $5M | $2M | $-3M | $-6M | $5M | $3M | |
| Free Cash Flow | $-8M | $-16M | · | $-22M | $-13M | $-10M | $-2M | $-8M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | $-8M | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| Net Margin | · | · | · | · | · | -479.0% | -733.8% | 84565.5% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | -479.0% | -733.8% | 107982.8% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| ROA | -76.2% | -78.3% | · | -64.6% | -21.2% | -23.3% | -99.2% | -51.6% | · | · | · | · | |
| ROE | -151.4% | -157.5% | · | -86.8% | -17.9% | -18.8% | -99.9% | -55.2% | · | · | · | · | |
| ROIC | · | · | · | · | · | · | · | -73.7% | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.8 | · | 33.0 | 38.4 | 25.0 | 3.6 | 1.9 | · | · | · | · | |
| Quick Ratio | 3.2 | 4.1 | · | 30.6 | 38.0 | 24.7 | 3.5 | 1.7 | · | · | · | · | |
| Interest Coverage | · | · | · | -19414.5 | -3555.2 | -1198.2 | · | -1084.9 | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.1 | -0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | 3.4 | 20.4 | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.46 | $0.94 | · | $4.86 | $0.80 | $0.75 | $0.73 | $2.23 | · | · | · | · | |
| Cash Flow / Share | $-0.73 | $-1.62 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.51 | $0.97 | · | $4.57 | $0.60 | $0.47 | $0.21 | $0.09 | · | · | · | · | |
| EPS (TTM) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · | · | $-0.07 | $0.03 | $-0.03 | $-3.30 | $-2.40 | $-0.01 |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | $7M | $78.0K | $78.0K | $78.0K | · | · | |
| Net Income TTM | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| Market Cap | $14M | $21M | · | $16M | $760M | $1.15B | $211M | $1.29B | · | · | · | · | |
| P/E | -1.3 | -1.2 | -0.9 | -0.4 | · | · | -85.7 | 1440.0 | -2400.0 | -42.5 | -133.5 | -15120.0 | |
| P/S | 6.8 | 10.3 | · | 8.0 | 380.9 | 570.8 | 32.1 | 16581.0 | · | · | · | · | |
| P/B | 2.1 | 2.2 | · | 0.4 | 9.8 | 21.9 | 8.2 | 19.3 | · | · | · | · | |
| P / Tangible Book | 2.1 | 2.2 | 0.7 | 0.4 | 13.0 | 34.4 | · | · | · | · | · | · | |
| P / Cash Flow | -1.6 | -1.2 | · | -0.7 | -59.8 | -116.9 | -134.9 | -156.0 | · | · | · | · | |
| P / FCF | -1.6 | -1.2 | · | -0.7 | -59.5 | -114.2 | -123.5 | -155.5 | · | · | · | · | |
| Earnings Yield | -79.6% | -85.2% | -108.7% | -244.6% | · | · | -1.2% | 0.07% | -0.04% | -2.4% | -0.75% | -0.01% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $105.0K | $225.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $2M | $1M | $2M | $954.0K | $1M | $1M | $2M | $3M | $4M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | |
| SG&A Expense | $1M | $1M | $862.0K | $1M | $986.0K | $981.0K | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | |
| Operating Expenses | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $5M | $5M | $4M | $5M | $4M | $4M | $5M | $5M | $6M | |
| Operating Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $-220.0K | · | $-320.0K | $-140.0K | · | $0 | $1.0K | |
| Other Non-op | $20.0K | $57.0K | $55.0K | $40.0K | $53.0K | $40.0K | $-36.0K | $103.0K | $105.0K | $202.0K | $202.0K | $278.0K | $173.0K | $-78.0K | $1.0K | $-6.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| EPS (Basic) | $-0.23 | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | $-0.70 | |
| EPS (Diluted) | $-0.23 | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.54 | $-0.70 | |
| Shares (Basic) | 13,788,000 | 13,786,000 | · | 10,991,000 | 10,174,000 | 10,174,000 | · | 10,174,000 | 10,174,000 | 10,174,000 | · | 10,153,000 | 10,065,000 | 8,143,000 | · | 8,143,000 | |
| Shares (Diluted) | 13,788,000 | 13,786,000 | · | 10,991,000 | 10,174,000 | 10,174,000 | · | 10,174,000 | 10,174,000 | 10,174,000 | · | 10,153,000 | 10,065,000 | 8,143,000 | · | 8,143,000 | |
| EBITDA | $-3M | $-2M | · | $-2M | $-2M | $-2M | · | $-5M | $-5M | $-4M | · | $-4M | · | $-5M | · | $-6M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $7M | $8M | $5M | $7M | $10M | $13M | $18M | $22M | $26M | $30M | $32M | $34M | $37M | $42M | |
| Prepaid Expense | $256.0K | $418.0K | $328.0K | $465.0K | $282.0K | $385.0K | $430.0K | $509.0K | $365.0K | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Current Assets | $3M | $6M | $8M | $9M | $7M | $9M | $12M | $14M | $20M | $24M | $29M | $32M | $36M | $37M | $40M | $45M | |
| PP&E (Net) | $69.0K | $81.0K | $93.0K | $106.0K | $107.0K | $127.0K | $153.0K | $181.0K | $211.0K | $244.0K | $271.0K | $252.0K | $305.0K | $338.0K | $342.0K | $378.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | $2M | |
| Total Assets | $5M | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | |
| Accounts Payable | $2M | $1M | $890.0K | $745.0K | $856.0K | $808.0K | $2M | $859.0K | $2M | $1M | $1M | $568.0K | $1M | $3M | $614.0K | $897.0K | |
| Current Liabilities | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $1M | $2M | |
| Capital Leases | $989.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | · | $10.0K | $27.0K | $57.0K | $119.0K | |
| Total Liabilities | $4M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $2M | $2M | $3M | $1M | $2M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $8.0K | $8.0K | |
| Retained Earnings | $-348M | $-345M | $-342M | $-340M | $-338M | $-336M | $-333M | $-330M | $-325M | $-320M | $-316M | $-311M | $-307M | $-303M | $-298M | $-293M | |
| Stockholders' Equity | $1M | $4M | $6M | $8M | $5M | $7M | $10M | $13M | $17M | $23M | $26M | $31M | $35M | $35M | $40M | $44M | |
| Liabilities + Equity | $5M | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | |
| Shares Outstanding | 13,789,000 | 13,787,000 | 13,784,000 | 13,041,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 8,143,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12.0K | $12.0K | $13.0K | $13.0K | $21.0K | $25.0K | $28.0K | $30.0K | $33.0K | $35.0K | $40.0K | $53.0K | $47.0K | $49.0K | $48.0K | $47.0K | |
| Stock-based Comp | $92.0K | $84.0K | $56.0K | $48.0K | $84.0K | $82.0K | $85.0K | $253.0K | $148.0K | $157.0K | $158.0K | $173.0K | $179.0K | $291.0K | $159.0K | $216.0K | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-1M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-6M | $-3M | $-5M | $-9M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | $0 | $8.0K | $59.0K | $0 | $14.0K | $45.0K | $12.0K | · | |
| Investing Cash Flow | · | · | $0 | · | · | · | $0 | $0 | $0 | $-8.0K | $-59.0K | $0 | $-14.0K | $-45.0K | $-12.0K | · | |
| Stock Issued | · | · | $0 | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | · | · | $1M | · | · | · | · | · | · | · | $0 | $0 | $4M | $-7.0K | $-7.0K | $-7.0K | |
| Net Change in Cash | $-3M | $-2M | $-704.0K | $3M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-2M | $-3M | $-5M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-3M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3032.4% | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -3013.3% | -1021.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -3032.4% | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -48.1% | -25.4% | · | -15.4% | -13.7% | -12.4% | · | -20.2% | -18.5% | -12.3% | · | -10.6% | · | -9.2% | · | -8.9% | |
| ROE | -99.2% | -40.3% | · | -20.1% | -18.1% | -15.4% | · | -22.8% | -20.5% | -13.8% | · | -11.2% | · | -9.6% | · | -9.1% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.7 | · | 5.8 | 3.7 | 4.6 | · | 7.3 | 7.4 | 10.3 | · | 16.7 | · | 11.8 | · | 27.7 | |
| Quick Ratio | 0.8 | 2.1 | · | 5.1 | 2.6 | 3.6 | · | 6.7 | 6.8 | 9.2 | · | 15.5 | · | 10.8 | · | 26.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 18.9 | · | 13.9 | · | · | · | -5694.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $0.30 | · | $0.59 | $0.52 | $0.72 | · | $1.25 | $1.71 | $2.22 | · | $3.02 | · | $4.26 | · | $5.39 | |
| Revenue / Share | $0.01 | $0.02 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.29 | · | · | · | $-0.44 | · | · | · | · | · | · | |
| Cash / Share | $0.16 | $0.34 | · | $0.59 | $0.47 | $0.68 | · | $1.28 | $1.78 | $2.15 | · | $2.92 | · | $4.17 | · | $5.16 | |
| EPS (TTM) | $-0.75 | $-0.72 | · | $-0.93 | $-1.23 | $-1.56 | · | $-1.82 | $-1.74 | $-1.62 | · | $-2.00 | $-2.29 | $-4.88 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-10M | $-9M | · | $-10M | $-13M | $-16M | · | $-19M | $-18M | $-17M | · | $-18M | $-20M | $-40M | · | $-38M | |
| Market Cap | $14M | $14M | · | $16M | $15M | $14M | · | $18M | $24M | $14M | · | $19M | · | $16M | · | $28M | |
| P/E | -1.4 | -1.4 | · | -1.3 | -1.2 | -0.9 | · | -1.0 | -1.3 | -0.9 | · | -0.9 | -1.0 | -0.4 | · | · | |
| P/S | · | · | · | 8.1 | 7.5 | 7.2 | · | 8.9 | 11.8 | 7.1 | · | 9.4 | · | 8.0 | · | 14.1 | |
| P/B | 13.9 | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | · | 0.5 | · | 0.6 | |
| P / Tangible Book | 13.9 | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | 0.7 | 0.5 | · | 0.6 | |
| P / Cash Flow | · | -6.0 | · | · | · | -4.9 | · | · | · | -3.2 | · | · | · | -5.2 | · | · | |
| Earnings Yield | -71.4% | -71.3% | · | -74.4% | -82.5% | -109.9% | · | -103.4% | -74.7% | -115.7% | · | -106.9% | -95.8% | -245.2% | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-9M | $-18M | $-18M | $-39M | $-14M |
| Seyreltilmiş Hisse Başı Kâr | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 3.7 | 4.8 | · | 33.0 | 38.4 |
| Cari Oran | 3.2 | 4.1 | · | 30.6 | 38.0 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-8M | $-16M | · | $-22M | $-13M |
Kurumsal Sahipler (13F) 28 dosya · $1.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
28
Tutulan Değer
$1.4M
Yeni pozisyonlar
6
Çıkan pozisyonlar
6
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (+2 önceki Ç'ye göre) | 6 (+3 önceki Ç'ye göre) | 3 (-3 önceki Ç'ye göre) | 7 (+3 önceki Ç'ye göre) | +336K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $376.139 | 358.228 | 26,77% | Hisse senetleri |
| VANGUARD GROUP INC | $258.444 | 263.987 | 18,40% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $188.609 | 179.628 | 13,43% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $184.148 | 175.379 | 13,11% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $80.034 | 76.208 | 5,70% | Hisse senetleri |
| BlackRock, Inc. | $77.433 | 73.746 | 5,51% | Hisse senetleri |
| CITADEL ADVISORS LLC | $47.374 | 45.118 | 3,37% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $33.480 | 31.886 | 2,38% | Hisse senetleri |
| XTX Topco Ltd | $30.809 | 29.342 | 2,19% | Hisse senetleri |
| JANE STREET GROUP, LLC | $27.049 | 25.761 | 1,93% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $25.217 | 24.016 | 1,80% | Hisse senetleri |
| STATE STREET CORP | $21.570 | 20.543 | 1,54% | Hisse senetleri |
| Parallel Advisors, LLC | $13.197 | 12.569 | 0,94% | Hisse senetleri |
| NORTHERN TRUST CORP | $12.517 | 11.921 | 0,89% | Hisse senetleri |
| Ground Swell Capital, LLC | $11.290 | 10.752 | 0,80% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $6.570 | 6.257 | 0,47% | Hisse senetleri |
| UBS Group AG | $4.340 | 4.133 | 0,31% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $4.183 | 3.984 | 0,30% | Hisse senetleri |
| MORGAN STANLEY | $915 | 871 | 0,07% | Hisse senetleri |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $858 | 817 | 0,06% | Hisse senetleri |
| Clean Yield Group | $439 | 418 | 0,03% | Hisse senetleri |
| NVWM, LLC | $88 | 84 | 0,01% | Hisse senetleri |
| BARCLAYS PLC | $44 | 42 | 0,00% | Hisse senetleri |
| SBI Securities Co., Ltd. | $35 | 33 | 0,00% | Hisse senetleri |
| HRT FINANCIAL LP | $21 | 20.336 | 0,00% | Hisse senetleri |
| VIMA LLC | $18 | 17 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 9 | 0,00% | Hisse senetleri |
| Motiv8 Investments LLC | $0 | 42 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Phillip Frost, M.D., Frost Gamma Investments Trust ×6 başvurular | 07 Ağustos 2026 | 13,90% | Değişiklik | Pasif yatırım | SEC |
| OPKO HEALTH, INC., FROST PHILLIP MD ET AL, Frost Gamma Investments Trust, Rubin Steven D ×5 başvurular | 07 Ağustos 2026 | 29,60% | İlk başvuru | Pasif yatırım | SEC |
| FiveT Investment Management Ltd, FiveT Capital AG | 25 Mayıs 2021 | · | İlk başvuru | · | SEC |
| Raymond F. Schinazi, Phillip Frost, M.D., Frost Gamma Investments Trust, Gary Wilcox, Roger Kornberg, Steven D. Rubin ×3 başvurular | 19 Mart 2019 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 18 içeriden öğrenenler · 9 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| James Sapirstein | Chief Executive Officer | 03 Haziran 2026 A | · | 0 | 0 | $0 |
| Sam Lee | President and Co-CEO | 09 Ocak 2026 A | 76.355 | 0 | 0 | $0 |
| James Joseph Martin | Co-CEO and CFO | 09 Ocak 2026 A | 44.167 | 0 | 0 | $0 |
| Gary Wilcox | Chief Executive Officer | 22 Haziran 2020 A | 16.948.605 | 0 | 0 | $0 |
| Jeffery A. Meckler | CHIEF EXECUTIVE OFFICER | 15 Mart 2016 P | 657.161 | 0 | 0 | $0 |
| Curtis Dale | INTERIM CFO | 24 Kasım 2015 A | · | 0 | 0 | $0 |
| Gerald A Mcguire | CHIEF FINANCIAL OFFICER | 13 Nisan 2015 A | · | 0 | 0 | $0 |
| Douglas L Mayers | CHIEF MEDICAL OFFICER | 01 Ekim 2015 A | · | 0 | 0 | $0 |
| Walt Addison Linscott | GENERAL COUNSEL AND SECRETARY | 21 Temmuz 2015 A | · | 0 | 0 | $0 |
| Phillip Frost, M.D. | Yönetim kurulu üyesi | 05 Ağustos 2026 P | 1.993.551 | 11 | 0 | $300.525 |
| Anthony J Japour | Yönetim kurulu üyesi | 09 Ocak 2026 A | 14.924 | 0 | 0 | $0 |
| Roger D. Kornberg | Yönetim kurulu üyesi | 09 Ocak 2026 A | 28.109 | 0 | 0 | $0 |
| Steven D Rubin | Yönetim kurulu üyesi | 09 Ocak 2026 A | 2.660.242 | 0 | 0 | $0 |
| Richard C Pfenniger JR | Yönetim kurulu üyesi | 09 Ocak 2026 A | 31.400 | 0 | 0 | $0 |
| Fred Hassan | Yönetim kurulu üyesi | 09 Ocak 2026 A | 1.383.009 | 0 | 0 | $0 |
| David S Block | Yönetim kurulu üyesi | 21 Eylül 2018 A | 168.696 | 0 | 0 | $0 |
| HSIAO JANE PH D | Yönetim kurulu üyesi | 21 Eylül 2018 A | 3.435.294 | 0 | 0 | $0 |
| Raymond F Schinazi | 10% sahip | 04 Mayıs 2021 S | 7.674.960 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
COCP Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
Medyan hedef
$9.00
+686,0%
2 28,6%
Güçlü Al
4 57,1%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
2 analist · 2026-09-29Ortalama hedef $9.00 +686,0%
← Tüm hedeflerin altında
Mevcut fiyat $1.15
Düşük$8.00
Ortalama$9.00
Yüksek$10.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026